Javascript must be enabled to continue!
Do N‐Terminal Pro‐C‐Type Natriuretic Peptide Levels Relate to Severity of Preeclampsia?
View through CrossRef
Aim
. To compare the plasma N‐terminal pro‐C‐type natriuretic peptide concentrations of normotensive pregnant women, patients with mild preeclampsia, and patients with severe preeclampsia.
Methods
. We collected venous blood samples from 25 normotensive pregnant women, 15 patients with mild preeclampsia, and 15 patients with severe preeclampsia. The women were at 30th to 40th weeks of gestation and in an age range of 20 to 35. The N‐terminal pro‐C‐type natriuretic peptide levels were measured by ELISA. Statistical comparisons were made by one‐way analysis of variance, Kruskal–Wallis, and Mann–Whitney
U
tests.
Results
. The median (interquartile range‐IQR) values of the N‐terminal pro‐C‐type natriuretic peptide were 6.48 (3.33) pmol/L in the normotensive women group, 7.37 (3.43) pmol/L in patients with mild preeclampsia, and 11.52 (6.13) pmol/L in patients with severe preeclampsia. The N‐terminal pro‐C‐type natriuretic peptide was significantly elevated in the severe preeclampsia study group (
P
< 0.001), whereas there was no significant difference between those with mild preeclampsia and the normotensive groups (
P
> 0.05).
Conclusion
. Our data indicate that the plasma concentration of the N‐terminal pro‐C‐type natriuretic peptide is significantly increased in patients with severe preeclampsia, but not in patients with mild preeclampsia. The severity of preeclampsia may be related to the circulating levels of the N‐terminal pro‐C‐type natriuretic peptide concentrations.
Title: Do N‐Terminal Pro‐C‐Type Natriuretic Peptide Levels Relate to Severity of Preeclampsia?
Description:
Aim
.
To compare the plasma N‐terminal pro‐C‐type natriuretic peptide concentrations of normotensive pregnant women, patients with mild preeclampsia, and patients with severe preeclampsia.
Methods
.
We collected venous blood samples from 25 normotensive pregnant women, 15 patients with mild preeclampsia, and 15 patients with severe preeclampsia.
The women were at 30th to 40th weeks of gestation and in an age range of 20 to 35.
The N‐terminal pro‐C‐type natriuretic peptide levels were measured by ELISA.
Statistical comparisons were made by one‐way analysis of variance, Kruskal–Wallis, and Mann–Whitney
U
tests.
Results
.
The median (interquartile range‐IQR) values of the N‐terminal pro‐C‐type natriuretic peptide were 6.
48 (3.
33) pmol/L in the normotensive women group, 7.
37 (3.
43) pmol/L in patients with mild preeclampsia, and 11.
52 (6.
13) pmol/L in patients with severe preeclampsia.
The N‐terminal pro‐C‐type natriuretic peptide was significantly elevated in the severe preeclampsia study group (
P
< 0.
001), whereas there was no significant difference between those with mild preeclampsia and the normotensive groups (
P
> 0.
05).
Conclusion
.
Our data indicate that the plasma concentration of the N‐terminal pro‐C‐type natriuretic peptide is significantly increased in patients with severe preeclampsia, but not in patients with mild preeclampsia.
The severity of preeclampsia may be related to the circulating levels of the N‐terminal pro‐C‐type natriuretic peptide concentrations.
Related Results
Natriuretic Peptide Receptors in Human Artery and Vein and Rabbit Vein Graft
Natriuretic Peptide Receptors in Human Artery and Vein and Rabbit Vein Graft
Abstract
Natriuretic peptides elicit their biological effects by elevation of cGMP through activation of two biologically active receptors: natriuretic peptide A recept...
e0380 Associations between plasma N-terminal pro brain natriuretic peptide and oxidative stress in patients with chronic stable coronary artery disease
e0380 Associations between plasma N-terminal pro brain natriuretic peptide and oxidative stress in patients with chronic stable coronary artery disease
Objectives
The present study was aimed to explore whether plasma N-terminal pro brain natriuretic peptide was associated with oxidative stress in patients with ch...
Identification of a rational, physiologically based early biomarker and pathogenic pathway For preeclampsia
Identification of a rational, physiologically based early biomarker and pathogenic pathway For preeclampsia
<p>Preeclampsia is a hypertensive disorder of pregnancy that is diagnosed after the 20th week of gestation. It is defined by the American College of Obstetrics and Gynecology...
Single vs. Recurrent Episodes of Preeclampsia-population–based Epidemiological and Clinical Characteristics
Single vs. Recurrent Episodes of Preeclampsia-population–based Epidemiological and Clinical Characteristics
Abstract
Objective:
The aims of this study were to determine the differences between women with single vs. recurrent episodes of preeclampsia in ...
Amino-Terminal Pro–Brain Natriuretic Peptide, Brain Natriuretic Peptide, and Troponin T for Prediction of Mortality in Acute Heart Failure
Amino-Terminal Pro–Brain Natriuretic Peptide, Brain Natriuretic Peptide, and Troponin T for Prediction of Mortality in Acute Heart Failure
Abstract
Background: Combining testing for natriuretic peptides [amino-terminal pro–brain natriuretic peptide (NT-proBNP) and brain natriuretic peptide (BNP)] and ca...
Serum catestatin level in preeclampsia
Serum catestatin level in preeclampsia
Background/Aim: Preeclampsia, a significant cause of maternal morbidity and mortality, is linked to increased cardiovascular risks. Catestatin regulates cardiovascular function whi...
Complicaciones asociadas a la preeclampsia en pacientes atendidas en el Hospital de Supe – Lima – 2021
Complicaciones asociadas a la preeclampsia en pacientes atendidas en el Hospital de Supe – Lima – 2021
Objetivo: Determinar las complicaciones asociadas a la preeclampsia en pacientes atendidas en el Hospital de Supe – Lima - 2021 Metodología: Estudio de tipo Observacional, trasvers...
Secretion of Brain Natriuretic Peptide in Cultured Human Coronary Vascular Smooth Muscle Cells
Secretion of Brain Natriuretic Peptide in Cultured Human Coronary Vascular Smooth Muscle Cells
Abstract
Brain natriuretic peptide (BNP) is a peptide of cardiac origin which regulates plasma volume as well as vascular tone and growth. Recently, we have reported...

